{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:11:47Z","timestamp":1785190307743,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Industrial Crossroads Research Fund from Shanghai Jiaotong University","award":["No. YG2024QNB12"],"award-info":[{"award-number":["No. YG2024QNB12"]}]},{"name":"Clinical Innovation Project from Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine","award":["No.23XHCR22C"],"award-info":[{"award-number":["No.23XHCR22C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06824-5","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:49:52Z","timestamp":1769150992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of a pre-phase with dexamethasone followed by fractionated R-CHOP in diffuse large B-cell lymphoma patients with gastrointestinal involvement at diagnosis"],"prefix":"10.1007","volume":"105","author":[{"given":"Ke","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"8","key":"6824_CR1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1200\/JCO.1994.12.8.1673","volume":"12","author":"F d\u2019Amore","year":"1994","unstructured":"d\u2019Amore F, Brincker H, Gr\u00f8nbaek K (1994) etal. Non-Hodgkin\u2019s lymphoma of the Gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma study group. J Clin Oncol 12(8):1673\u20131684","journal-title":"J Clin Oncol"},{"issue":"4","key":"6824_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/0016-5085(94)90742-0","volume":"106","author":"MH Amer","year":"1994","unstructured":"Amer MH, el-Akkad S (1994) Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology 106(4):846\u2013858","journal-title":"Gastroenterology"},{"key":"6824_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107406","volume":"135","author":"Q Lai","year":"2023","unstructured":"Lai Q, Zhao Y, Yan H, Peng H (2023) Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL. Leuk Res 135:107406","journal-title":"Leuk Res"},{"issue":"6","key":"6824_CR4","first-page":"393","volume":"60","author":"CR Flowers","year":"2010","unstructured":"Flowers CR, Sinha R, Vose JM (2010) Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin 60(6):393\u2013408","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"6824_CR5","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/annonc\/mdt188","volume":"24","author":"R Vaidya","year":"2013","unstructured":"Vaidya R, Habermann TM, Donohue JH et al (2013) Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol 24(9):2439\u20132443","journal-title":"Ann Oncol"},{"key":"6824_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-016-0821-9","volume":"14","author":"Z Ge","year":"2016","unstructured":"Ge Z, Liu Z, Hu X (2016) Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma. World J Surg Oncol 14:85","journal-title":"World J Surg Oncol"},{"issue":"5","key":"6824_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, d\u2019Amore F, Coiffier B et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5(5):397\u2013400","journal-title":"Ann Oncol"},{"key":"6824_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/CMAR.S295671","volume":"13","author":"Y Shen","year":"2021","unstructured":"Shen Y, Ou J, Wang B, Wang L, Xu J, Cen X (2021) Influence of severe gastrointestinal complications in primary gastrointestinal diffuse large B-cell lymphoma. Cancer Manag Res 13:1041\u20131052","journal-title":"Cancer Manag Res"},{"issue":"9","key":"6824_CR9","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3109\/10428194.2015.1014366","volume":"56","author":"Y Cui","year":"2015","unstructured":"Cui Y, Li X, Sun Z et al (2015) Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma. Leuk Lymphoma 56(9):2613\u20132618","journal-title":"Leuk Lymphoma"},{"key":"6824_CR10","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.2147\/CMAR.S260974","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu Y, Zhao P et al (2020) Switching fractioned R-CHOP cycles to standard R-CHOP cycles guided by endoscopic ultrasonography in treating patients with primary gastric diffuse large B-Cell lymphoma. Cancer Manag Res 12:5041\u20135048","journal-title":"Cancer Manag Res"},{"issue":"3","key":"6824_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cam4.1982","volume":"8","author":"T Kadota","year":"2019","unstructured":"Kadota T, Seo S, Fuse H et al (2019) Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP. Cancer Med 8(3):982\u2013989","journal-title":"Cancer Med"},{"issue":"3","key":"6824_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0929-6646(09)60305-3","volume":"105","author":"MC Chang","year":"2006","unstructured":"Chang MC, Huang MJ, Su YW, Chang YF, Lin J, Hsieh RK (2006) Clinical outcome of primary gastric lymphoma treated with chemotherapy alone or surgery followed by chemotherapy. J Formos Med Assoc 105(3):194\u2013202","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"6824_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1245\/s10434-006-9069-x","volume":"13","author":"G Spectre","year":"2006","unstructured":"Spectre G, Libster D, Grisariu S et al (2006) Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy. Ann Surg Oncol 13(11):1372\u20131378","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6824_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-021-01156-5","volume":"14","author":"JA Park","year":"2021","unstructured":"Park JA, Wang L, Cheung NV (2021) Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. J Hematol Oncol 14(1):142","journal-title":"J Hematol Oncol"},{"issue":"19","key":"6824_CR15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364(19):1844\u20131854","journal-title":"N Engl J Med"},{"issue":"9","key":"6824_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384(9):842\u2013858","journal-title":"N Engl J Med"},{"issue":"12","key":"6824_CR17","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the groupe d\u2019etudes des lymphomes de l\u2019adulte. Blood 116(12):2040\u20132045","journal-title":"Blood"},{"issue":"1","key":"6824_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ejh.12304","volume":"93","author":"S Kreher","year":"2014","unstructured":"Kreher S, Lammer F, Augustin D, Pezzutto A, Baldus CD (2014) R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma. Eur J Haematol 93(1):70\u201376","journal-title":"Eur J Haematol"},{"issue":"7","key":"6824_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1470-2045(19)30091-9","volume":"20","author":"H Tilly","year":"2019","unstructured":"Tilly H, Morschhauser F, Bartlett NL et al (2019) Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study. Lancet Oncol 20(7):998\u20131010","journal-title":"Lancet Oncol"},{"issue":"1","key":"6824_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11\u201348","journal-title":"Clin Nutr"},{"issue":"5","key":"6824_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/bjh.18348","volume":"198","author":"M Picardi","year":"2022","unstructured":"Picardi M, Giordano C, Pugliese N et al (2022) Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: preliminary results of a single-centre phase II study. Br J Haematol 198(5):847\u2013860","journal-title":"Br J Haematol"},{"issue":"10","key":"6824_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/dc.21450","volume":"39","author":"P Zeppa","year":"2011","unstructured":"Zeppa P et al (2011) Impact of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in lymph nodal and mediastinal lesions: a multicenter experience. Diagn Cytopathol 39(10):723\u2013729","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"6824_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1148\/radiol.14132154","volume":"272","author":"M Picardi","year":"2014","unstructured":"Picardi M et al (2014) Advanced-stage Hodgkin lymphoma: US\/chest radiography for detection of relapse in patients in first complete remission\u2014a randomized trial of routine surveillance imaging procedures. Radiology 272(1):262\u2013274","journal-title":"Radiology"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06824-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06824-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:40Z","timestamp":1771398220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06824-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6824"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06824-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}